lymphomas of indistinguishable histology. 1, 2 Several clinical features of primary CNS lymphoma suggest that these tumors exhibit a distinct biological phenotype: 1) a short duration of response to combined modality therapy; 2) a unique proclivity to grow only in the CNS; 3) a heightened responsiveness to methotrexate, the most important agent used in the treatment of this disease. Dissemination of lymphoma cells within the CNS, occurring as a secondary event, is also associated with poor prognosis. 9 CNS metastases of lymphoma are a devastating complication of non-Hodgkin lymphoma. Unlike malignant gliomas which are highly vascular tumors, both primary and metastatic CNS lymphomas exhibit angiotropism; 10 the brain is the only tissue environment in which large B-lymphoma cells accumulate densely around tumor vessels, suggesting that the CNS vasculature may contribute significantly to the pathogenesis of this type of lymphoma (Fig. 1A ). Insights
For personal use only. on April 20, 2017 . by guest www.bloodjournal.org From into the molecular pathogenesis of CNS lymphomas are likely relevant to the devastating complication of systemic lymphoma relapse within the CNS. 
Patients, materials and methods

Study
Purification of Total RNA from Frozen Lymphoma Specimens or from Non-Neoplastic
Brain: lymphoma cell nuclei accounted for at least 70% of all cells in each tumor used in this analysis as determined by histopathologic analysis of hematoxylin and eosin stained sections used in parallel. Depending on tumor size, between three and sixteen 14-micron thick tissue sections were prepared using a cryostat. Samples were placed in RLT buffer plus 1% β-ME, homogenized, and RNA prepared according to the animal tissue protocol of the RNeasy handbook (Qiagen, Valencia, CA). RNA was quantified based on absorbance at 260 nm. Quality of RNA was assured by measuring OD 260:280 ratios.
RNA amplification and labeling: 1 microgram total sample RNA was linearly amplified through one round of modified in vitro transcription exactly in parallel with Universal Human Reference RNA (Stratagene, La Jolla, CA). 11, 12 Pearson coefficient for the amplification steps was at least 0.75 and for self-self hybridization was at least 0.95. 13 For personal use only. on April 20, 2017 . by guest www.bloodjournal.org From Amplified RNA was converted to amino-allyl modified cDNA and coupled to Nhydroxysuccinimidyl esters of Cy3 or Cy5 (Amersham-Pharmacia, Inc) and then hybridized to a microarray slide at 65°C for 12-16 hours. The slide was then washed and immediately scanned with Axon Imager 4000B (Axon Instruments, Union City, CA), utilizing GenePix Pro3 software.
Expression Microarray Preparation: The 20,862 cDNAs used in these studies were from
Research Genetics (Huntsville, AL). On the basis of unigene build 166, these clones represent 19,740 independent loci. Briefly, clones were PCR-amplified using universal primers and precipitated, dissolved in 3X SSC and printed on poly-L-lysine-coated slides.
Slides were postprocessed using standard protocols. Microarrays from five different print runs were used in this study. Identity of clones described in this manuscript were verified by resequencing. Hybridization, washing, scanning and primary data analysis was performed as described.
Microarray Data Pre-processing: The images were quantified using genepix and the background-corrected ratios of the median signal of Cy5 and Cy3 channels were formed for each spot and log-transformed (base 2) with the replicate spots averaged. Each array was normalized by applying subarray median normalization.
14 A spot was retained if it was present in at least 80% of the experiments and has shown at least two-fold change in at least one experiment. Missing values were imputed by using the median value for a given gene computed over 5 samples most highly correlated with the sample containing a missing value for that gene. The process was repeated until no more missing values remained. Finally, spots for which the average value among CNS lymphomas was less than the average value among normal brain samples were removed from the analysis.
Thus, all spots remaining had to have at least twice over-expression relative to the normal brain considering that there were not more than 30% of normal brain cell present in the CNS samples.
Data Analysis: Data were analyzed using freely available R statistical software version (V. 1.7, 15 ). The genes were tested for significant association with outcome using twotailed t-test with equal variance. The unadjusted P-values were assessed by repeatedly shuffling the labels and recomputing the absolute value of the t-statistic. Thus, the Pvalue was assigned by computing the proportion of times the permutation-based statistic exceeded the observed one. The adjustment of the P-value was done using the false discovery rate approach under an assumption of independence. 16 Clustering of genes and lymphoma samples in our dataset was done using agglomerative hierarchical clustering using Eucledian metric and Ward method.
Differentiation analysis of PCNSL: We applied a nearest centroid method 17, 18 with
Pearson correlation as a similarity measure to assign the 32 primary CNS and lymphnode large B-cell lymphomas in our dataset to corresponding subtypes (ABC, GCB, type 3). We identified 38 matching genes among the 100 genes used to assign lymphoma subclass as defined by Rosenwald et al. 5 In the case of multiple probes, values were averaged. We further centered and scaled each gene in our dataset as well as the phospho-STAT6 (P-STAT6) was from Upstate Biotechnology. Immunohistochemistry for P-STAT6 was performed as described. 19 Confocal immunofluorescence microscopy was performed using a Zeiss LSM 510 Meta microscope using multiphoton 488 nm and 543 nm laser excitation. Images were acquired using a 63X/1.4 NA Plan-Apochromat oil immersion objective. Anti-IgG goat-anti-mouse FITC secondary antibody was used to recognize anti-VWF and anti-IgG goat anti-rabbit Alexa 594 was used to recognize anti-IL-4. DAPI counterstain was used to visualize cell nuclei. Brightness and contrast of images were modified for publication. For in situ hybridization, 12 micron frozen sections were fixed in 4% paraformaldehyde and adjacent sections subjected to in situ hybridization using sense and antisense IL-4 riboprobes as described. 20 The IL-4 gene was isolated using human IL-4 gene specific oligonucleotides and RT-PCR, cloned into Bluescript vector and verified by sequencing. IL-4 riboprobes were generated in an in vitro transcription reaction using the pBluescript IL-4 plasmid. summarized. 21 Relative expression was calculated as described. 22 The cDNA equivalent 
Quantitative RT-PCR:
Results
Molecular Features of Primary CNS Lymphoma
We used cDNA microarrays to define the features of gene expression in tumors from immunocompetent patients with primary CNS lymphoma that are most distinct from systemic large B-cell lymphoma. We analyzed the gene expression pattern of 23 primary CNS lymphoma diagnostic specimens -all of large B-cell histology, and compared these to nine consecutive cases of large B-cell lymphoma isolated from peripheral lymph nodes.
Over 460 genes exhibited highly significant differential expression between the nodal and CNS lymphomas (false discovery rate <0.01) (Fig. 1B , Table 1 ). CNS lymphomas were distinguished by activation of genes involved in apoptosis, cell proliferation, the unfolded protein response pathway and by distinct molecular interactions with the stromal environment. For example, CNS lymphomas exhibited significantly higher expression of cathepsin-D while nodal lymphomas expressed higher levels of matrix metalloproteinase-2, ADAM-12, and E-cadherin. Expression of CD11c, a marker of monocytes and dendritic cells, was also higher in systemic large B-cell lymphomas obtained from lymph nodes.
In addition, primary CNS lymphomas were distinguished from nodal lymphomas by high expression of the oncogenes Pim-1 and c-Myc. Mina53, a recently-described Myc-induced nuclear antigen involved in cell proliferation, was also expressed at higher levels in primary CNS lymphoma, supporting a role for c-Myc pathway in the pathogenesis of brain lymphomas. 23 Mina53 has not previously been reported to be expressed in lymphoma.
CNS lymphomas are also characterized by high expression of XBP-1 and activating transcription factor 6 (ATF-6), each basic leucine-zipper transcription factors which regulate the UPR. 24 ATF-6 has been shown to induce expression of XBP-1. 25 Both XBP-1 and ATF-6 regulate expression of an overlapping subset of endoplasmic reticulum chaperone genes as well as other target genes, including c-Myc in the UPR in MEF cells. 26 We used data described by Alizadeh et al., 4 and by Rosenwald et al. 5 and their subtype assignments to subclassify the primary CNS lymphomas in our dataset. We used 38 shared unique gene identifiers which are present on our array platform and which are among the 100 genes used by Rosenwald et al. to classify large B-lymphomas as ABC, GCB, and type 3. After recentering and scaling genes in our and Rosenwald's datasets, we first verified that 38 genes are sufficient to recover original subtypes in the Rosenwald dataset. We thus proceeded to classify the lymphomas in our study using the Rosenwald classification into ABC, GCB and type 3 subtypes. We found that all three molecular subtypes of systemic diffuse large B-cell lymphoma were represented in the nodal lymphomas used in our study: 7 out of 9 lymph node lymphomas were assigned to the GCB subtype; one of the nodal lymphomas was assigned to the ABC subtype and one to the type 3 subtype. PCNSL cases (all large B-cell lymphomas) were assigned among the three subtypes equally with 8 tumors each assigned to the ABC and GCB subgroups and 7 tumors assigned to the type 3 subgroup.
In addition, we noted overlapping expression of germinal center genes such as bcl-6 and activation genes such as cyclin D2 among specimens classified as ABC-type ( Figure 1C ). This observation is consistent with the findings of recent immunohistochemical studies which have detected coexpression of a germinal center marker bcl-6 and an activation marker MUM-1 in the majority of primary CNS lymphomas, suggesting an overlapping state of differentiation ( Figure 1C ) 7, 27 We used quantitative real-time PCR to validate the cDNA microarray data, focusing on several genes likely to be significant in the pathogenesis of CNS lymphoma (Fig. 1D ). There was strong agreement between the quantitative real-time PCR data and the cDNA microarray results. In addition, we analyzed expression of CNS lymphoma marker genes in three consecutive cases of secondary CNS lymphoma -systemic large Bcell lymphomas which had metastasized to brain. We found that secondary CNS lymphomas also exhibited high levels of c-Myc, Pim-1, and XBP-1 compared to nodal large B-cell lymphomas. This finding is consistent with the hypothesis that a factor(s) in the brain tumor microenvironment induces some but not all of the transcriptional characteristics of primary CNS lymphoma.
XBP-1 was among the most significantly differentially expressed genes in CNS lymphomas (FDR < 0.004). We used immunohistochemistry to characterize its pattern of expression and found evidence for the strongest XBP-1 protein expression in dense populations of tumor cells closely associated with the vasculature in CNS lymphomas (Fig. 2) . Large B-cell lymphoma cells in lymph nodes exhibited lower XBP-1 immunoreactivity overall and there was no relationship between XBP-1 immunoreactivity and the tumor vasculature (10/10 specimens analyzed with at least 4 fields/specimen at X-100 power). These findings suggest that XBP-1 expression in primary CNS lymphoma is at least partially regulated by paracrine interactions with the CNS vasculature.
Interleukin-4 Expression and Lymphoma Angiotropism
We A number of IL-4 target genes were expressed at significantly higher levels in CNS lymphomas compared to nodal lymphomas including cathepsin-D, src-like adapter protein, caspase 8 and FADD-like apoptosis regulator (FLICE), as well as XBP-1 ( Table   1 , Figure 1C) . 30 These results suggest that autocrine and paracrine IL-4 production in CNS lymphomas has a significant role in the biology of this tumor, possibly through
For personal use only. on April 20, 2017 . by guest www.bloodjournal.org From regulation of the activity of Janus kinase 1 which we demonstrated to be expressed at significantly higher levels in CNS lymphomas compared to nodal lymphomas (Table 1) . IL-4 has been shown to potentiate anti-apoptotic mechanisms in B-lymphocytes as well as resistance to chemotherapy in cancer cells. 36, 37 IL-4-dependent gene expression is mediated by the activation of the signaling and transcription factor STAT6.
To provide evidence for STAT6 activation in CNS lymphoma tumors, we performed an immunohistochemical analysis of phosphorylated STAT6 (P-STAT6) in diagnostic CNS lymphoma specimens. There was reproducible expression of P-STAT6 both by the tumor endothelia and by lymphoma cells, with evidence for particularly strong activation in the vessel microenvironment, supporting a role for STAT6 as a mediator of IL4 signaling in CNS lymphoma ( Figure 5 ). We did not detect activated STAT6 expression by tumor endothelia in 8/8 nodal diffuse large B-cell lymphomas; focal expression of activated STAT6 expression by tumor cells was detected in one of these specimens.
In addition, we characterized STAT6 activation in an independent set of 20 cases of primary CNS lymphoma derived from a population of immunocompetent patients with B-cell PCNSL, all of whom were treated with a high-dose methotrexate-containing regimen (3-8 gm/m 2 ) and evaluated at the University of California, San Francisco (radiation was reserved for patients with relapsed disease refractory to intravenous methotrexate). Tumors which contained at least one focus in which dense populations of lymphoma cells scored positive for nuclear P-STAT6 expression were associated with early disease progression and short overall survival in comparison with tumors of low cellular density or tumors which exhibited sparse or absent P-STAT6 expression ( Fig   5D, E) . Taken together these results provide independent lines of evidence which
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Discussion
Here we identify several molecular features of primary CNS lymphoma, some of which are distinct from large B-cell lymphoma isolated from lymph nodes. While individual primary CNS lymphomas may be assigned to ABC, GCB or a type 3 subclass of differentiation, our data suggest some overlap in expression of GCB and ABC markers in this disease. This observation is consistent with recent immunohistochemical data which demonstrates that a majority of primary CNS lymphomas express both bcl-6 (a GCB marker) as well as MUM-1 (an ABC marker), suggesting an overlapping histogenetic time-slot of B-cell differentiation. 27 We demonstrate for the first time that tumor cells as well as endothelia in CNS lymphomas express IL-4, a B-cell growth and survival factor and provide evidence that IL-4 signal transduction is associated with tumor progression in CNS lymphoma.
Several IL-4 target genes including XBP-1 are among the most significantly differentially expressed genes in CNS lymphomas. In addition, we demonstrate that increased expression of activated STAT6 by tumor cells and endothelia in CNS lymphoma predicts early progression and short survival in an independent set of patients all treated with high-dose methotrexate-based chemotherapy. We propose that detection of nuclear expression of P-STAT6 in dense populations of tumor cells may be a clinically useful biomarker to delineate prognosis in the evaluation of formalin-fixed diagnostic specimens in primary CNS lymphoma. apoptosis. 40 In addition, we detected a significant correlation between high IL-4 RNA levels and decreased expression in CNS lymphomas of F1Aα, an apoptotic mediator and death-receptor binding protein (data not shown). 41 We did not detect a correlation between intratumoral IL-4 expression and subclass of CNS lymphoma as GCB, ABC and type 3.
While the IL-4 target gene bcl-6, a marker of GC origin, was detectable in CNS lymphomas both by gene expression and by immunohistochemistry, its level of expression was similar overall compared to the nodal lymphomas. There are also conflicting data on the significance of bcl-6 as an immunohistochemical marker of prognosis in CNS lymphoma with two out of three published studies finding no significant correlation of bcl-6 with survival. 7, 27, 42 The pathophysiology of tumor angiotropism in CNS lymphoma may recapitulate a normal adaptation of the brain microvasculature to facilitate the rapid induction of B- 
39,45
For personal use only. on April 20, 2017 . by guest www.bloodjournal.org From Table 1 . Table of the most significantly differentially expressed genes in CNS and nodal large B-cell lymphomas. False discovery rate (FDR) corresponds to the expected proportion of falsely called genes among the genes declared to be differentially expressed. RAWP corresponds to the permutation-based unadjusted p-value. Figure 1(A) . Angiotropic growth pattern in primary CNS lymphoma. Hematoxylin and Eosin. Specimens used for gene expression analysis in this study were more highly cellular, consisting of at least 70% tumor cells. 
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